PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 187 filers reported holding PDL BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 2.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $53,000 | +12.8% | 20,000 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $47,000 | -20.3% | 20,000 | 0.0% | 0.01% | -22.2% |
Q1 2018 | $59,000 | +7.3% | 20,000 | 0.0% | 0.01% | +12.5% |
Q4 2017 | $55,000 | -27.6% | 20,000 | -11.1% | 0.01% | -33.3% |
Q3 2017 | $76,000 | +35.7% | 22,500 | 0.0% | 0.01% | +20.0% |
Q2 2017 | $56,000 | +9.8% | 22,500 | 0.0% | 0.01% | +11.1% |
Q1 2017 | $51,000 | +6.2% | 22,500 | 0.0% | 0.01% | +12.5% |
Q4 2016 | $48,000 | -36.0% | 22,500 | 0.0% | 0.01% | -42.9% |
Q3 2016 | $75,000 | -36.4% | 22,500 | -40.0% | 0.01% | -36.4% |
Q2 2016 | $118,000 | -11.3% | 37,500 | -6.2% | 0.02% | -15.4% |
Q1 2016 | $133,000 | 0.0% | 40,000 | +6.7% | 0.03% | 0.0% |
Q4 2015 | $133,000 | -29.6% | 37,500 | 0.0% | 0.03% | -29.7% |
Q3 2015 | $189,000 | -21.6% | 37,500 | 0.0% | 0.04% | -14.0% |
Q2 2015 | $241,000 | -8.7% | 37,500 | 0.0% | 0.04% | -10.4% |
Q1 2015 | $264,000 | -8.7% | 37,500 | 0.0% | 0.05% | -12.7% |
Q4 2014 | $289,000 | +3.2% | 37,500 | 0.0% | 0.06% | +3.8% |
Q3 2014 | $280,000 | -22.9% | 37,500 | 0.0% | 0.05% | -23.2% |
Q2 2014 | $363,000 | +16.3% | 37,500 | 0.0% | 0.07% | +11.3% |
Q1 2014 | $312,000 | -1.3% | 37,500 | 0.0% | 0.06% | -3.1% |
Q4 2013 | $316,000 | +5.7% | 37,500 | 0.0% | 0.06% | -4.5% |
Q3 2013 | $299,000 | +3.5% | 37,500 | 0.0% | 0.07% | -5.6% |
Q2 2013 | $289,000 | – | 37,500 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Argent Trust Co | 41,405 | $102,270 | 0.01% |
Diversified Trust Co | 11,029 | $26,469 | 0.00% |
HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
Ancora Advisors LLC | 4,948 | $0 | 0.00% |
Westside Investment Management, Inc. | 500 | $0 | 0.00% |